About Ectosense
Ectosense is a company based in Leuven (Belgium) founded in 2015 by Frederik Massie was acquired by ResMed in October 2021. Ectosense has raised $1.91 million across 2 funding rounds from investors including ResMed, Saffelberg Investments and imec.istart. The company has 1 employees as of March 29, 2024. Ectosense offers products and services including NightOwl Sensor and NightOwl Companion App. Ectosense operates in a competitive market with competitors including Oura, Muse, Biotricity, Nyxoah and SleepScore Labs, among others.
- Headquarter Leuven, Belgium
- Employees 1 as on 29 Mar, 2024
- Founders Frederik Massie
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ectosense India Private Limited
- Date of Incorporation 06 Aug, 2020
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$168.8 K (USD)533.18as on Mar 31, 2022
-
Net Profit
$16.36 K (USD)363.78as on Mar 31, 2022
-
EBITDA
$23.7 K (USD)389.78as on Mar 31, 2022
-
Total Equity Funding
$1.91 M (USD)
in 2 rounds
-
Latest Funding Round
$1.85 M (USD), Seed
Mar 16, 2018
-
Investors
ResMed
& 2 more
-
Employee Count
1
as on Mar 29, 2024
-
Acquired by
ResMed
(Oct 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ectosense
Ectosense offers a comprehensive portfolio of products and services, including NightOwl Sensor and NightOwl Companion App.
Device for monitoring patient health data remotely.
App for managing and accessing sensor data.
Funding Insights of Ectosense
Ectosense has successfully raised a total of $1.91M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.85 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ectosense
Ectosense has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ResMed, Saffelberg Investments and imec.istart.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Funding solutions for tech startups are provided by the accelerator.
|
Locked | Locked | Locked | |
|
Therapeutic devices to treat sleep apnea and respiratory disorders
|
Locked | Locked | Locked |
Investor details for Ectosense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ectosense
Investment portfolio details for Ectosense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ectosense
Detailed financials for Ectosense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ectosense Comparisons
Peer comparison for Ectosense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ectosense
Ectosense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oura, Muse, Biotricity, Nyxoah and SleepScore Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
|
| Locked | Locked | Locked |
EEG-powered headbands for meditation and sleep biofeedback are developed.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
Provider of a neurostimulation device for obstructive sleep apnea treatments
|
|
| Locked | Locked | Locked |
Sleep quality is monitored via bedside devices and mobile apps.
|
|
| Locked | Locked | Locked |
Sleep quality is monitored via Dreem's wearable EEG device.
|
Detailed competitors of Ectosense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ectosense
Complete news archive for Ectosense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ectosense
Ectosense was founded in 2015.
Ectosense is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Ectosense is a funded company, having raised a total of $1.91M across 2 funding rounds to date.
As of Mar 29, 2024, the latest employee count at Ectosense is 1.
Annual revenue of Ectosense is $168.8K as on Mar 31, 2022.
Provider of connected solutions for monitoring sleep disorders. The device is called NightOwl, which is used in home-based sleep apnea tests.
Ectosense offers NightOwl Sensor and NightOwl Companion App.
Ectosense has 3 investors. Key investors include ResMed, Saffelberg Investments, and imec.istart.